Heritage Insurance Holdings, Inc. (HRTG) Stock Price & Analysis
Heritage Insurance Holdings, Inc. (HRTG) closed at USD 34.73 on Wednesday, October 28, 2026, down 4.09% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 36.21; the Oct 28, 2026 session ranged USD 34.55–36 on volume of 209,982 shares. Market capitalization is $1.03B, with a 52-week range of USD 20.48–37.87 (NYQ). Source: Nexqual, retrieved October 29, 2026 at 06:54 UTC.
Also available as compact Markdown for AI agents: nexqual.com/HRTG.md
Latest Earnings Results (HRTG)
Heritage Insurance Holdings, Inc. (HRTG) reported Q3 2026 results on Oct 28, 2026, 4:25:14 PM ET: GAAP EPS $1.72 vs. estimate $0.93 (beat), revenue $219.24M vs. estimate $217.34M (beat). Source: SEC 8-K filing. Nexqual published it 41 seconds after release. Read the SEC filing.
| Fiscal period | EPS (reported) | Revenue | Released | Source |
|---|---|---|---|---|
| Q3 2026 | $1.72 (GAAP diluted) | $219.2M | Oct 28, 2026, 4:25:14 PM ET · on Nexqual +41 seconds | SEC 8-K filing |
Reported actuals captured by Nexqual from SEC 8-K filings and company press releases; each figure confirmed by two independent extraction methods.
Key facts (HRTG)
- Last four reported quarters (through Jun 30, 2026): revenue $855M, net income $215M (25.2% margin), free cash flow $298M (SEC filings).
- Valuation: P/E 4.8x (avg 4.8x at the last 3 fiscal year-ends), EV/EBITDA 1.7x, net cash $516M.
- Insider open-market sales, last ~7 months: 16 Form 4 filings, $3.8M; 7 not under a Rule 10b5-1 plan ($1.9M); 5 by opportunistic insiders (4 outside 10b5-1 plans), 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $377K; 1 by opportunistic insiders, 0 by routine insiders.
- Analysts: Buy (mean 2.25 on a 1–5 scale) (4 analysts), mean target USD 39 (range 36–42).
- Total return with dividends: 1Y +50.5% vs S&P 500 +13.6%; 5Y +450.6% vs S&P 500 +79.8%.
- Next earnings: 2026-10-28, EPS estimate USD 1.19, revenue estimate $216M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (HRTG)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $632M | $662M | $735M | $817M | $847M | $855M |
| Operating income | -$68.1M | -$157M | $63.2M | $93.6M | $267M | $295M |
| Net income | -$74.7M | -$154M | $45.3M | $61.5M | $196M | $215M |
| EPS (diluted) | -$2.69 | -$5.86 | $1.73 | $2.01 | $6.32 | — |
| Free cash flow | $59.1M | -$42.8M | $60.5M | $78.9M | $174M | $298M |
| Operating margin | -10.8% | -23.8% | 8.6% | 11.5% | 31.5% | 34.5% |
| Net margin | -11.8% | -23.3% | 6.2% | 7.5% | 23.1% | 25.2% |
| Revenue growth | +6.4% | +4.9% | +11.0% | +11.1% | +3.7% | — |
| Cash + short-term investments | $359M | $281M | $464M | $453M | $559M | — |
| Total debt | $121M | $129M | $120M | $116M | $78.4M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (HRTG)
P/E 4.8x · P/S 1.2x · EV/EBITDA 1.7x · EV/Sales 0.6x · P/FCF 3.5x · P/B 1.8x · FCF yield 28.83% · Earnings yield 20.85% · Net cash $516M · EV $516M
P/E at fiscal year-ends: Dec 2025 4.6x, Dec 2024 6.0x, Dec 2023 3.8x.
Insider sales (SEC Form 4, open-market, last ~7 months) (HRTG)
9 of 16 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-10-19 | Johns Timothy E | See Remarks | 3,500 | $126K | 16% | Yes (adopted May 20, 2026) | Too little history (no open-market trades in 2023–2025) |
| 2026-09-18 | Johns Timothy E | See Remarks | 3,500 | $122K | 13.8% | Yes (adopted May 20, 2026) | Too little history (no open-market trades in 2023–2025) |
| 2026-09-14 | Garateix Ernie J | Chief Executive Officer | 2,500 | $88K | 0.2% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-09-09 | Binnun Sharon | Chief Accounting Officer | 6,565 | $222K | 7.5% | No | Too little history (no open-market trades in 2023 or 2024) |
| 2026-09-03 | Garateix Ernie J | Chief Executive Officer | 2,500 | $88K | 0.2% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-09-01 | Binnun Sharon | Chief Accounting Officer | 9,200 | $312K | 9.5% | Yes (adopted December 12, 2025) | Too little history (no open-market trades in 2023 or 2024) |
| 2026-08-24 | Garateix Ernie J | Chief Executive Officer | 10,000 | $349K | 1% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-08-19 | Johns Timothy E | See Remarks | 3,500 | $118K | 12.1% | Yes (adopted May 20, 2026) | Too little history (no open-market trades in 2023–2025) |
| 2026-08-17…2026-08-18 | Garateix Ernie J | Chief Executive Officer | 10,000 | $344K | 0.9% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-08-17 | Lusk Kirk | Chief Financial Officer | 10,000 | $342K | 2% | No | Too little history (no open-market trades in 2023) |
| 2026-08-10 | Moura Timothy | See Remarks | 15,104 | $491K | 9.4% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-03 | Binnun Sharon | Chief Accounting Officer | 9,200 | $276K | 8.7% | Yes (adopted December 12, 2025) | Too little history (no open-market trades in 2023 or 2024) |
| 2026-07-01 | Binnun Sharon | Chief Accounting Officer | 9,200 | $244K | 8% | Yes (adopted December 12, 2025) | Too little history (no open-market trades in 2023 or 2024) |
| 2026-06-22 | Binnun Sharon | Chief Accounting Officer | 9,200 | $224K | 7.4% | Yes (adopted December 12, 2025) | Too little history (no open-market trades in 2023 or 2024) |
| 2026-05-01 | Binnun Sharon | Chief Accounting Officer | 9,200 | $267K | 6.9% | Yes (adopted December 12, 2025) | Too little history (no open-market trades in 2023 or 2024) |
| 2026-04-20 | Garateix Ernie J | Chief Executive Officer | 8,334 | $230K | 0.8% | Yes (adopted June 13, 2025) | Opportunistic (traded every year 2023–2025, no repeating month) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Insider purchases (SEC Form 4, open-market, last ~7 months) (HRTG)
1 purchase, $377K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-05-19 | Whiting Paul L | Director | 16,000 | $377K | 23.56 | Opportunistic (traded every year 2023–2025, no repeating month) |
Analysts (HRTG)
Consensus Buy (mean 2.25 on a 1–5 scale), 4 analysts; mean target USD 39 (low 36, high 42).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-16 | Raymond James | Initiated | Market Perform | |
| 2026-08-07 | Truist Securities | Target raised | Buy | $36 → $42 |
| 2026-07-15 | Piper Sandler | Target raised | Overweight | $27 → $31 |
Total return (dividends reinvested) (HRTG)
| 1Y (from 2025-10-29) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +50.5% | +450.6% |
| S&P 500 (SPY) | +13.6% | +79.8% |
| Per year | +50.8% | +40.6% |
| Volatility (annualized) | 50.2% | 71.9% |
| Max drawdown | -33.0% (Nov 2025→Jun 2026) | -80.8% (Mar 2022→Nov 2022) |
HRTG earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| Aug 5, 2026 | Quarter ended Jun 30, 2026 | $2.05 | $1.25 | Beat +64.0% | +18.2% |
| May 7, 2026 | Quarter ended Mar 31, 2026 | $1.19 | $1.53 | Miss −22.2% | -22.0% |
| Mar 9, 2026 | Quarter ended Dec 31, 2025 | $2.15 | $1.74 | Beat +23.6% | -1.2% |
| Feb 23, 2026 | Quarter ended Dec 31, 2025 | $2.15 | $1.74 | Beat +23.6% | +14.8% |
| Nov 5, 2025 | — | — | — | — | +16.5% |
| Aug 5, 2025 | — | — | — | — | -10.3% |
| May 6, 2025 | — | — | — | — | +21.5% |
| Mar 11, 2025 | — | — | — | — | +6.2% |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).
HRTG recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Oct 28, 2026 | 8-K | Quarterly results |
| Sep 25, 2026 | Schedule 13G/A | Raymond T. Hyer: 7.0% of shares, passive 5%+ holder (amended) |
| Aug 7, 2026 | 10-Q | Quarterly report · period ended Jun 30, 2026 |
| Aug 5, 2026 | 8-K | Quarterly results |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
HRTG suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Supplier | Citrus Re | “In order to limit our potential exposure to catastrophic events, we purchase significant reinsurance from third party reinsurers and may sponsor catastrophe bonds issued by Citrus Re Ltd.” |
Quoted from the company's 10-K filed Mar 12, 2026.
HRTG analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $1.19 | $1.32 | -10.2% | $215.7M | 4 |
| Next quarter (ends Mar 2027) | $1.27 | $1.27 | +0.2% | $217.0M | 4 |
| Current fiscal year (ends Dec 2026) | $5.25 | $4.37 | +20.2% | $859.9M | 3 |
| Next fiscal year (ends Dec 2027) | $5.09 | $4.73 | +7.5% | $887.2M | 4 |
HRTG options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 23 | 73.1% | ±14.8% |
| Dec 18, 2026 | 51 | 52.0% | ±15.9% |
| Mar 19, 2027 | 142 | 50.1% | ±25.0% |
| Jun 17, 2027 | 232 | 50.9% | ±32.1% |
30-day implied volatility 70.4% vs 26.9% realized over the last 30 trading days. Put/call ratio (volume) 1.79. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 29, 2026 at 06:54 UTC)
| Price | USD 34.73 |
|---|---|
| Change | ▼ 4.09% (down) |
| Previous Close | USD 36.21 |
| Open | USD 35.91 |
| Day Range | USD 34.55 – 36 |
| 52-Week Range | USD 20.48 – 37.87 |
| Volume | 209,982 shares |
| Market Cap | $1.03B |
| Exchange | NYQ |
Technical Analysis (HRTG)
Nexqual's technical model rates HRTG "BUY" based on 4 bullish and 2 bearish signals across 127 daily candles, as of October 29, 2026 at 06:54 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 43.44 (neutral) |
| vs SMA50 | Above (USD 34.71) |
| MACD | 0.62 (positive) |
Analyst Ratings (HRTG)
Wall Street analysts rate HRTG "Buy" based on 4 analysts, with a mean price target of USD 39 (range USD 36–42), per Nexqual as of October 29, 2026 at 06:54 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 39 |
| High Target | USD 42 |
| Low Target | USD 36 |
| Buy / Hold / Sell | 2 / 2 / 0 |
Earnings (HRTG)
| Next Earnings Date | 2026-10-28 |
|---|---|
| EPS Estimate | USD 1.19 |
| Revenue Estimate | $215.68M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 1.72 vs est 0.93 ▲ beat |
| 2026-06-30 | USD 2.05 vs est 1.25 ▲ beat |
| 2026-03-31 | USD 1.19 vs est 1.53 ▼ miss |
| 2025-12-31 | USD 2.15 vs est 1.74 ▲ beat |
Source: Nexqual, October 29, 2026 at 06:54 UTC.
Financials & Fundamentals (HRTG)
| Total Revenue | $854.63M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +3.00% |
| Gross Margin | +45.39% |
| Operating Margin | +39.15% |
| Profit Margin | +25.19% |
| ROE | +45.28% |
| Debt / Equity | 0.16 |
| Current Ratio | 0.82 |
| Total Cash | $587.60M |
| Total Debt | $91.83M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $297.75M (34.8% of revenue) |
Source: Nexqual, October 29, 2026 at 06:54 UTC.
Financial Health Score (HRTG)
Nexqual rates Heritage Insurance Holdings, Inc.'s overall financial health "Solid" across five dimensions, as of October 29, 2026 at 06:54 UTC.
| Growth | Mixed — Revenue +3.7% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 45%, operating 34% (last 12 months) |
| Balance Sheet | Solid — $588M cash and investments vs $71M debt (Jun 2026, SEC), net cash |
| Cash Flow | Strong — FCF $298M (last 4 quarters to Jun 2026, SEC), 35% margin |
| Efficiency | Strong — ROE 38%, ROA 8.8% (last 4 quarters, SEC) |
Ownership (HRTG)
| Insider Ownership | +19.74% |
|---|---|
| Institutional Ownership | +67.53% |
| Shares Outstanding | 29.73M |
| Float | 22.67M |
| Short % of Float | +2.92% |
Source: Nexqual, October 29, 2026 at 06:54 UTC.
Leadership (HRTG)
Heritage Insurance Holdings, Inc. is led by Ernesto Jose Garateix CPCU, CEO & Director, per Nexqual as of October 29, 2026 at 06:54 UTC.
| CEO & Director | Ernesto Jose Garateix CPCU |
|---|---|
| CFO, Company Secretary & Treasurer | Kirk Howard Lusk |
| President of Narragansett Bay Insurance Company | Timothy Michael Moura |
| President of Zephyr Insurance Company | Timothy E. Johns |
Major Backers & Investors (HRTG)
Notable institutional backers of Heritage Insurance Holdings, Inc. include American Century Companies Inc, Fidelity, Connor Clark & Lunn Investment Management Ltd, according to Nexqual as of October 29, 2026 at 06:54 UTC.
Active Investors
| Investor | Stake |
|---|---|
| American Century Companies Inc | 3.59% |
| Fidelity | 1.87% |
| Connor Clark & Lunn Investment Management Ltd | 1.86% |
| Pacific Ridge Capital Partners, LLC | 1.68% |
| Jane Street Group, LLC | 1.61% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 7.85% |
| Vanguard Group | 6.6% |
| Dimensional Fund Advisors | 4.41% |
| Geode Capital | 2.52% |
| State Street | 1.9% |
Source: Nexqual, October 29, 2026 at 06:54 UTC.
From Heritage Insurance Holdings, Inc.'s Latest SEC 10-K Filing (filed 2026-03-12)
Key Strengths & Strategy (as disclosed to the SEC)
- We believe our proprietary data analytics capabilities and underwriting processes allow us to make better risk selections leading to profitability and high levels of policy retention.
- Our underwriting team leverages our proprietary data analytics, which include a number of automated processes, to analyze a number of risk evaluation factors, including the age, construction, location and value of the residence, premiums to be received from insuring the residence, geographic concentrations of policies and the cost of reinsurance.
- We are vertically integrated and control or manage substantially all aspects of insurance underwriting, customer service, financial reporting and actuarial analysis, distribution and claims processing and adjusting.
- To encourage our Florida policyholders to allow us to manage their claims from beginning to end, we developed a program that provides participating customers with a 10% discount on their claim deductible, and gives us control over inspection, claims adjusting and repair services.
Partnerships
- As further described in Note 13 Reserve for Losses, the Company's 2017 reinsurance agreement with the FHCF was commuted during the third quarter of 2023.
- NBIC writes personal residential insurance policies through a network of retail independent agents, wholesale agents and a partnership with a large direct agency.
Legal & Regulatory Risks (Item 1A, quoted)
- We are subject to extensive regulation which may reduce our profitability or limit our growth. Moreover, if we fail to comply with these regulations, we may be subject to penalties, including fines and suspensions, which may adversely affect our financial condition and results of operations.
- We cannot predict with certainty the effect any enacted, proposed or future state or federal legislation or NAIC initiatives may have on the conduct of our business.
- Our insurance subsidiaries are subject to minimum capital and surplus requirements, and our failure to meet these requirements could subject us to regulatory action.
- Litigation or regulatory actions could have a material adverse impact on us.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HMN | Horace Mann Educators Corporati | USD 45.8 | ▼ 1.02% |
| PRCH | Porch Group, Inc. | USD 16.3 | ▼ 7.7% |
| HCI | HCI Group, Inc. | USD 195.24 | ▼ 2.36% |
| SKWD | Skyward Specialty Insurance Gro | USD 57.96 | ▼ 1.08% |
| SLDE | Slide Insurance Holdings, Inc. | USD 27.19 | ▼ 4.23% |
| LMND | Lemonade, Inc. | USD 45.36 | ▼ 1.2% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 06:54 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt